A
1.56
0.01 (0.65%)
| Penutupan Terdahulu | 1.55 |
| Buka | 1.58 |
| Jumlah Dagangan | 133,230 |
| Purata Dagangan (3B) | 328,267 |
| Modal Pasaran | 94,494,536 |
| Harga / Buku (P/B) | 1.25 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -1.94 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.15% |
| Nisbah Semasa (MRQ) | 8.02 |
| Aliran Tunai Operasi (OCF TTM) | -102.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -63.62 M |
| Pulangan Atas Aset (ROA TTM) | -31.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -55.68% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Acumen Pharmaceuticals, Inc. | Menurun | Menurun |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.38 |
|
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.46% |
| % Dimiliki oleh Institusi | 72.24% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Knollwood Investment Advisory, Llc | 30 Sep 2025 | 1,628,510 |
| Julat 52 Minggu | ||
| Median | 8.00 (412.82%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B of A Securities | 18 Nov 2025 | 8.00 (412.82%) | Beli | 1.66 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |